Satellos Bioscience Inc (MSCLF)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | MSCLF | AZN | AMGN | GILD | VRTX |
| Company | Satellos Bioscience Inc | Astrazeneca Plc | Amgen Inc | Gilead Sciences Inc | Vertex Pharmaceutic |
| Price Information | |||||
| Exchange | OTC US | NYSE | NASDAQ | NASDAQ | NASDAQ |
| Open | 0.9000 | 190.81 | 369.38 | 144.23 | 475.14 |
| High | 0.9400 | 192.51 | 370.89 | 146.13 | 476.17 |
| Low | 0.8800 | 190.54 | 364.72 | 142.68 | 461.13 |
| Latest | 0.9230 | 192.01 | 366.25 | 145.21 | 466.10 |
| Change | +0.0128 | +2.11 | +0.04 | +0.22 | -3.24 |
| % Change | +1.41% | +1.11% | +0.01% | +0.15% | -0.69% |
| Volume | 352,900 | 1,828,860 | 2,099,000 | 3,697,200 | 1,496,700 |
| 20-Day Average Volume | 194,185 | 1,978,895 | 2,500,385 | 6,439,890 | 1,410,860 |
| Previous Close | 0.9102 | 189.90 | 366.21 | 144.99 | 469.34 |
| Industry | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical | Medical - Biomedical |
| Has Options | No | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 0.6869 | 200.86 | 376.34 | 147.98 | 477.20 |
| 20-Day Raw Stochastic | 85.38% | 11.39% | 16.24% | 18.98% | 26.95% |
| 20-Day Relative Strength | 71.99 | 46.36 | 50.82 | 52.31 | 48.44 |
| Weighted Alpha | +84.28 | +31.10 | +23.00 | +39.82 | -0.93 |
| Today's Opinion | 100% Buy | 56% Buy | 88% Buy | 88% Buy | 72% Buy |
| Previous Opinion | 100% Buy | 56% Buy | 88% Buy | 88% Buy | 72% Buy |
| Last Month's Opinion | 48% Buy | 100% Buy | 100% Buy | 100% Buy | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | +18.49% since 01/22/26 | -1.51% since 03/09/26 | -2.84% since 03/09/26 | -0.97% since 03/09/26 | +1.13% since 03/09/26 |
| Low | 0.7816 on 01/23/26 | 189.43 on 03/13/26 | 364.72 on 03/16/26 | 142.68 on 03/16/26 | 461.13 on 03/16/26 |
| High | 1.0000 on 01/28/26 | 198.09 on 03/10/26 | 380.14 on 03/11/26 | 149.38 on 03/10/26 | 507.92 on 03/10/26 |
| 1-Month | |||||
| %Chg | +85.56% since 12/29/25 | -6.59% since 02/13/26 | -0.80% since 02/13/26 | -6.30% since 02/13/26 | -5.16% since 02/13/26 |
| Low | 0.4732 on 12/31/25 | 189.35 on 03/09/26 | 361.39 on 03/05/26 | 142.68 on 03/16/26 | 450.67 on 03/06/26 |
| High | 1.0000 on 01/28/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 156.01 on 02/18/26 | 507.92 on 03/10/26 |
| 3-Month | |||||
| %Chg | +67.94% since 10/29/25 | +5.10% since 12/16/25 | +12.09% since 12/16/25 | +22.25% since 12/16/25 | +2.45% since 12/16/25 |
| Low | 0.4419 on 11/14/25 | 178.08 on 01/21/26 | 318.21 on 01/05/26 | 116.88 on 01/05/26 | 429.00 on 01/20/26 |
| High | 1.0000 on 01/28/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| 6-Month | |||||
| %Chg | +124.25% since 07/29/25 | +23.78% since 09/16/25 | +34.12% since 09/16/25 | +30.99% since 09/16/25 | +19.10% since 09/16/25 |
| Low | 0.3865 on 08/01/25 | 145.79 on 09/25/25 | 269.77 on 09/26/25 | 108.46 on 10/02/25 | 374.17 on 09/24/25 |
| High | 1.0000 on 01/28/26 | 212.71 on 02/18/26 | 391.29 on 03/02/26 | 157.29 on 02/11/26 | 507.92 on 03/10/26 |
| Key Statistics | |||||
| Market Capitalization, $K | 171,223 | 294,517,408 | 197,412,080 | 179,993,632 | 119,228,320 |
| Shares Outstanding, K | 185,507 | 1,550,908 | 539,068 | 1,241,421 | 254,034 |
| Annual Sales | 0 | 58,739,000,000 | 36,751,000,000 | 29,443,000,000 | 12,001,300,000 |
| Annual Net Income | -20,510,000 | 10,225,000,000 | 7,711,000,000 | 8,510,000,000 | 3,953,200,000 |
| Last Quarter Sales | 0 | 15,503,000,000 | 9,866,000,000 | 7,925,000,000 | 3,190,000,000 |
| Last Quarter Net Income | -5,820,000 | 2,321,000,000 | 1,333,000,000 | 2,183,000,000 | 1,191,100,000 |
| 60-Month Beta | 1.10 | 0.32 | 0.45 | 0.37 | 0.31 |
| Per-Share Information | |||||
| Most Recent Earnings | -0.03 on 11/14/25 | 2.12 on 02/10/26 | 5.29 on 02/03/26 | 1.86 on 02/10/26 | 5.03 on 02/12/26 |
| Latest Earnings Date | 03/25/26 | 05/05/26 | 05/07/26 | 04/23/26 | 05/04/26 |
| Most Recent Dividend | N/A | 2.170 on 02/20/26 | 2.520 on 02/13/26 | 0.820 on 03/13/26 | N/A |
| Next Ex-Dividends Date | N/A | 02/20/26 | 05/15/26 | 03/13/26 | N/A |
| Ratios | |||||
| Price/Earnings ttm | 0.00 | 20.73 | 16.76 | 17.79 | 28.58 |